Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amygdala-targeted Temporal Interference Stimulation for Major Depressive Disorder。

NCT07829575 is registered in ClinicalTrials.gov with Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University as lead sponsor.

NCT NCT07829575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07829575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amygdala-targeted Temporal Interference Stimulation for Major Depressive Disorder。
Lead sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
December 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd